Anthim IM and stability testing
Ended Definitive Contract Awarded Last action
- Contract number
- W9113M10C0024
- Awardee
-
Elusys Therapeutics Inc. UEI ELP1DCK8L191
- Awarding agency
-
ACC Redstone
Army Contracting Command, Department of Defense
- Obligated
- $734,898
Award facts
- Contract value 100% obligated
- $735,626.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Pine Brook, Montville, NJ, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$728 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $248,197 | |
| Original award | $487,429 |
Quick answers
Who was awarded contract W9113M10C0024?
W9113M10C0024 was awarded to Elusys Therapeutics Inc. by ACC Redstone (Army Contracting Command) on May 17, 2010.
How much is contract W9113M10C0024 worth?
The government has obligated $734,898 on W9113M10C0024. Its current value, with exercised options, is $735,626.
Was contract W9113M10C0024 competed?
The extent of competition for W9113M10C0024 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award